Výsledky vyhledávání - "Gry Irene Magnussen"

Akademický článek

High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy.

Autor: Gry Irene Magnussen, Ruth Holm, Elisabeth Emilsen, Anne Katrine Ree Rosnes, Ana Slipicevic, Vivi Ann Flørenes

Publikováno v: PLoS ONE, Vol 7, Iss 6, p e38254 (2012)

Notoriously resistant malignant melanoma is one of the most increasing forms of cancer worldwide; there is thus a precarious need for new treatment options. The Wee1 kinase is a major regulator of the G(2)/M checkpoint, and halts the cell cycle by ad

Externí odkaz: https://doaj.org/article/aae019a80a124e60945899bd54595848

Zobrazit plný text záznamu

Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)

Autor: Nils Meland, Egon Stenager, Roman Schmid, Jette L. Frederiksen, Gry Irene Magnussen, J. L. Vadgaard, Elena Pedersen, Michael Broksgaard Jensen

Publikováno v: Patient preference and adherence
Pedersen, E D, Stenager, E, Vadgaard, J L, Jensen, M B, Schmid, R, Meland, N, Magnussen, G & Frederiksen, J L 2018, ' Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device : a prospective open-label Scandinavian noninterventional study (the ScanSmart study) ', Patient Preference and Adherence, vol. 12, pp. 569-575 . https://doi.org/10.2147/PPA.S154417
Pedersen, E D, Stenager, E, Vadgaard, J L, Jensen, M B, Schmid, R, Meland, N, Magnussen, G & frederiksen, J L 2018, ' Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device : a prospective open-label scandinavian noninterventional study (The scansmart study) ', Patient Preference and Adherence, vol. 12, pp. 569-575 . https://doi.org/10.2147/PPA.S154417
Patient Preference and Adherence, Vol Volume 12, Pp 569-575 (2018)

Elena Didenko Pedersen,1,2 Egon Stenager,3,4 JL Vadgaard,5 MB Jensen,6 R Schmid,7 N Meland,8 G Magnussen,9 Jette L Frederiksen10,11 1Akershus University Hospital, Department of Neurology, Loerenskog, Norway; 2Sandvika Nevrosenter, Sandvika, Norway; 3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2a73a3ca5cb81e2fe18666fa13400b
https://doi.org/10.2147/ppa.s154417

Zobrazit plný text záznamu

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma

Autor: Ana Slipicevic, Viola Nähse-Kumpf, Roar Fjær, Karianne G. Fleten, Birgit Engesæter, Elisabeth Emilsen, Gry Irene Magnussen, Vivi Ann Flørenes

Publikováno v: BMC Cancer

Background Malignant melanoma has an increasing incidence rate and the metastatic disease is notoriously resistant to standard chemotherapy. Loss of cell cycle checkpoints is frequently found in many cancer types and makes the cells reliant on compen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::219933541a66175b673807d9a968968b
http://europepmc.org/articles/PMC4460948

Zobrazit plný text záznamu

Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma

Autor: Vivi Ann Flørenes, Birgit Engesæter, Elisabeth Emilsen, Anne Katrine Ree Rosnes, Hiep Phuc Dong, Gry Irene Magnussen, Susan Shahzidi

Publikováno v: Biochemical and biophysical research communications. 420(3)

The novel synthetic retinoid, CD437, shows potent anti-tumor activity in a range of different cancer cell lines and now serves as a prototype for development of new retinoid related molecules (RRMs). The purpose of this study was to examine the effec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d882e8362ca77d03dbc4b2e6d7724b94
https://pubmed.ncbi.nlm.nih.gov/22446330

Zobrazit plný text záznamu

Abstract 3417: Increased anticancer effect of combining Wee1 (MK1775) and Chk1 (AZD7762) inhibitors in malignant melanoma cell lines

Autor: Vivi Ann Flørenes, Elisabeth Emilsen, Birgit Engesæter, Gry Irene Magnussen

Publikováno v: Cancer Research. 73:3417-3417

Malignant melanoma is one of the most increasing forms of cancer worldwide, in addition to being notoriously resistant to therapy. Despite recent advances, there are no curative treatments once the cancer has spread (stage IV); there is thus a precar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d038eb933466b1eb766325df8e775a23
https://doi.org/10.1158/1538-7445.am2013-3417

Zobrazit plný text záznamu

Abstract 3056: High levels of Wee1 are associated with malignancy and has potential as a therapeutic target in malignant melanoma

Autor: Elisabeth Emilsen, Anne Katrine Ree Rosnes, Gry Irene Magnussen, Vivi Ann Flørenes

Publikováno v: Cancer Research. 72:3056-3056

Malignant melanoma is the most increasing form of cancer worldwide, in addition to being the second most common cancer in young adults. Whereas the prognosis is good when detected early, there are no curative treatments once the cancer has spread (st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::822f1dc6b9b58c47ae0340bcd2ab3c26
https://doi.org/10.1158/1538-7445.am2012-3056

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání